Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efpegerglucagon - Hanmi Pharmaceutical

Next Previous
Drug Profile

Efpegerglucagon - Hanmi Pharmaceutical

Alternative Names: LAPSGlucagon Analog; HM-15136

Latest Information Update: 10 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Hanmi Pharmaceutical
  • Class Antihypoglycaemics; Obesity therapies; Pancreatic hormones
  • Mechanism of Action Glucagon receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Autoimmune disorders; Congenital hyperinsulinism
  • New Molecular Entity No

Highest Development Phases

  • Phase II Congenital hyperinsulinism
  • Preclinical Obesity

Most Recent Events

  • 26 May 2025 Updated efficacy and adverse event data from a phase II trial in Congenital-hyperinsulinism released byHanmi Pharmaceutical
  • 16 Jan 2025 Efficacy, adverse event and pharmacokinetics data from a phase II trial in Congenital hyperinsulinism released by Hanmi Pharmaceutical
  • 28 May 2024 No recent reports of development identified for phase-I development in Congenital-hyperinsulinism in South Korea (IV)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top